- Home
- RFIL vs IMMX Comparison
RFIL vs IMMX Comparison
Compare RFIL & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- IMMX
- Stock Information
- Founded
- RFIL 1979
- IMMX 2014
- Country
- RFIL United States
- IMMX United States
- Employees
- RFIL N/A
- IMMX N/A
- Industry
- RFIL Electrical Products
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- RFIL Technology
- IMMX Health Care
- Exchange
- RFIL Nasdaq
- IMMX Nasdaq
- Market Cap
- RFIL 42.4M
- IMMX 46.8M
- IPO Year
- RFIL N/A
- IMMX 2021
- Fundamental
- Price
- RFIL $3.75
- IMMX $2.20
- Analyst Decision
- RFIL Strong Buy
- IMMX Strong Buy
- Analyst Count
- RFIL 1
- IMMX 1
- Target Price
- RFIL $4.50
- IMMX $7.00
- AVG Volume (30 Days)
- RFIL 8.6K
- IMMX 274.3K
- Earning Date
- RFIL 01-21-2025
- IMMX 11-12-2024
- Dividend Yield
- RFIL N/A
- IMMX N/A
- EPS Growth
- RFIL N/A
- IMMX N/A
- EPS
- RFIL N/A
- IMMX N/A
- Revenue
- RFIL $62,278,000.00
- IMMX N/A
- Revenue This Year
- RFIL N/A
- IMMX N/A
- Revenue Next Year
- RFIL $8.38
- IMMX $200.00
- P/E Ratio
- RFIL N/A
- IMMX N/A
- Revenue Growth
- RFIL N/A
- IMMX N/A
- 52 Week Low
- RFIL $2.61
- IMMX $1.26
- 52 Week High
- RFIL $4.65
- IMMX $7.50
- Technical
- Relative Strength Index (RSI)
- RFIL 34.00
- IMMX 56.24
- Support Level
- RFIL $4.07
- IMMX $1.88
- Resistance Level
- RFIL $4.39
- IMMX $2.33
- Average True Range (ATR)
- RFIL 0.16
- IMMX 0.29
- MACD
- RFIL -0.04
- IMMX -0.02
- Stochastic Oscillator
- RFIL 0.00
- IMMX 44.58
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.